The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2015
Filed:
Oct. 08, 2010
Applicants:
Kyung-hee Chun, Seoul, KR;
Seok-jun Kim, Bucheon-si, KR;
Teak-chin Cheong, Seoul, KR;
Il-ju Choi, Seoul, KR;
Yeon Su Lee, Goyang-si, KR;
Sang-jin Lee, Goyang-si, KR;
Inventors:
Kyung-Hee Chun, Seoul, KR;
Seok-Jun Kim, Bucheon-si, KR;
Teak-Chin Cheong, Seoul, KR;
Il-Ju Choi, Seoul, KR;
Yeon Su Lee, Goyang-si, KR;
Sang-Jin Lee, Goyang-si, KR;
Assignee:
National Cancer Center, Goyang-si, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/00 (2006.01); C12Q 1/68 (2006.01); G01N 33/53 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G01N 33/6845 (2013.01); G01N 2500/04 (2013.01); G01N 2500/02 (2013.01); C12Q 2600/136 (2013.01); G01N 33/5011 (2013.01); G01N 2333/4724 (2013.01); G01N 2333/9121 (2013.01); G01N 2440/14 (2013.01);
Abstract
Disclosed is a method for screening a novel cancer therapeutic agent. The cancer therapeutic agent exhibits down-regulation of galectin-3 and fascin-1 or interferes with the interaction between galectin-3 and GSK-3β.